LAES:NASDAQSEALSQ Corp Analysis
Data as of 2026-08-23 - not real-time
$2.54
Latest Price
9/10Risk
Risk Level: High
Executive Summary
SEALSQ Corp is priced at $2.54 and its moving averages line up in bearish order, the shorter trailing the longer. Across the trailing 30 sessions it lost 9.3%. RSI sits at 45.3, which reads as neutral, and MACD momentum is bullish. Recent trading has carved out support near $2.22 and resistance around $3.07.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Analyst price targets sit 131.3% above the current price. Revenue is growing at 118.2% on a -187.3% profit margin.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 63.0%, a beta of 3.39 and a maximum drawdown of 72.7%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 1 out of 10.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Analyst price targets sit 131.3% above the current price. Revenue is growing at 118.2% on a -187.3% profit margin.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 63.0%, a beta of 3.39 and a maximum drawdown of 72.7%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 1 out of 10.
Top Market Events
Benzinga.com4monSEALSQ Earnings & ForecastsSEALSQ LAES last issued guidance on July 6, 2026 for fiscal year 2026. The...Geneva, Switzerland , Aug. 07, 2026 GLOBE NEWSWIRE -- August 7, 2026 — SEALSQ Corp NASDAQ: LAES 'SEALSQ' or the...Geneva, Switzerland, July 29, 2026 GLOBE NEWSWIRE -- SEALSQ Corp NASDAQ: LAES 'SEALSQ' or 'Company' , a company that...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 3.52
- MACD momentum is positive
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 3.52
- Analyst targets imply +131.3% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 1/10
Key Factors
- Negative profit margin of -187.3%
- Analyst targets imply +131.3% versus the current price
- Negative return on equity of -12.7%
Key Metrics & Analysis
Financial Health
Revenue Growth118.20%
Profit Margin-187.34%
P/E Ratio-12.1
ROE-12.71%
ROA-8.27%
Debt/Equity1.73
P/B Ratio1.1
Op. Cash Flow$-31257000
Free Cash Flow$-10687875
Industry P/E35.2
Technical Analysis
TrendBearish
RSI45.3
Support$2.22
Resistance$3.07
MA 20$2.56
MA 50$2.77
MA 200$3.52
MACDBullish
VolumeDecreasing
Fear & Greed Index94.41
Valuation
Target Price$5.88
Upside/Downside131.30%
GradeFair
TypeBlend
Risk Assessment
Beta3.39
Volatility63.02%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.